Our results regarding the administration of sivelestat after cerebral ischemia provide new insight into the pathophysiology of this ischemia, and we expect that the increase in levels of PGRN, and also the decrease in the levels of GRN, elicited by sivelestat, will lead to the establishment of a new treatment for acute cerebral ischemia. This evidence concerns the gene GRN and ischemia.